Why Co-Diagnostics Stock Rose 15.8% on Monday
Co-Diagnostics (NASDAQ: CODX) saw its shares rise 15.8% on Monday. The molecular diagnostics company, which closed at $9.41 on Thursday, opened at $9.50 on Monday and rose to $10.90 shortly after noon. The company is up more than 9.9% for the year. The stock is still closer to its 52-week low of $7.01 than its 52-week high of $20.68.
Image source: Getty Images.
The company didn't have any breaking news, but the continued rise in the omicron COVID-19 variant buoyed the company's stock. The company also announced last week that is is near to releasing its at-home COVID-19 test.
Source Fool.com